This specific ISBN edition is currently not available.View all copies of this ISBN edition:
A study of a revolutionary new approach to the treatment of obesity discusses the FDA's approval of a new appetite-control drug, Redux (dexfenfluramine), that produces dramatic results with fewer side effects and the use of Redux in a weight-loss program. 75,000 first printing. $75,000 ad/promo.
"synopsis" may belong to another edition of this title.
Sheldon Levine, M.D., a longtime weight loss specialist, has a private practice and is on staff at The Valley Hospital in Ridgewood, New Jersey. He received his medical degree from the University of Bologna in Italy in 1982, completed his residency at Mr. Carmel Mercy Hospital in Detroit, and did his fellowship at Albert Einstein College of Medicine in the Bronx, New York. He has been featured on Today, Larry King Live, CNN, and many other national shows. He lives with his family in New Jersey.
"About this title" may belong to another edition of this title.
Book Description William Morrow, 1996. Hardcover. Condition: New. Seller Inventory # DADAX0688151531
Book Description Condition: New. New. Seller Inventory # M-0688151531